NCT03329352View on ClinicalTrials.gov

Evaluation of a Full-Face Mask for the Treatment of Obstructive Sleep Apnea (OSA)

NACompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

November 3, 2017

Primary Completion Date

July 31, 2018

Study Completion Date

July 31, 2018

Conditions
Obstructive Sleep Apnea
Interventions
DEVICE

F&P Full-Face Mask

The F\&P full-face mask will serve as the participant's primary PAP therapy mask for the duration of the trial period (from Visit 2 to Visit 3). For participants taking part in the study extension, they will be using the trial full-face mask as their primary PAP therapy mask for 6 months after Visit 3.

Trial Locations (1)

76109

North Texas Lung and Sleep Clinic, Fort Worth

All Listed Sponsors
lead

Fisher and Paykel Healthcare

INDUSTRY

NCT03329352 - Evaluation of a Full-Face Mask for the Treatment of Obstructive Sleep Apnea (OSA) | Biotech Hunter | Biotech Hunter